HTG Molecular Diagnostics Inc (HTGMQ)
0.0025
0.00 (0.00%)
USD |
OTCM |
May 15, 11:15
HTG Molecular Diagnostics Total Assets (Quarterly): 10.87M for March 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | 10.87M |
| December 31, 2022 | 17.78M |
| September 30, 2022 | 13.61M |
| June 30, 2022 | 22.21M |
| March 31, 2022 | 28.46M |
| December 31, 2021 | 30.46M |
| September 30, 2021 | 34.51M |
| June 30, 2021 | 37.32M |
| March 31, 2021 | 36.63M |
| December 31, 2020 | 35.20M |
| September 30, 2020 | 36.71M |
| June 30, 2020 | 39.30M |
| March 31, 2020 | 41.93M |
| December 31, 2019 | 45.12M |
| September 30, 2019 | 50.93M |
| June 30, 2019 | 35.12M |
| March 31, 2019 | 36.41M |
| December 31, 2018 | 43.77M |
| Date | Value |
|---|---|
| September 30, 2018 | 44.91M |
| June 30, 2018 | 49.02M |
| March 31, 2018 | 53.35M |
| December 31, 2017 | 21.26M |
| September 30, 2017 | 17.24M |
| June 30, 2017 | 19.61M |
| March 31, 2017 | 11.40M |
| December 31, 2016 | 18.45M |
| September 30, 2016 | 23.19M |
| June 30, 2016 | 31.67M |
| March 31, 2016 | 39.75M |
| December 31, 2015 | 39.39M |
| September 30, 2015 | 44.54M |
| June 30, 2015 | 49.31M |
| March 31, 2015 | 7.666M |
| December 31, 2014 | 8.728M |
| September 30, 2014 | 12.11M |
| December 31, 2013 | 4.398M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
10.87M
Minimum
Mar 2023
50.93M
Maximum
Sep 2019
32.26M
Average
35.16M
Median
Total Assets (Quarterly) Benchmarks
| Viveve Medical Inc | 12.15M |
| Minerva Surgical Inc | 72.78M |
| Stereotaxis Inc | 41.91M |
| Electromed Inc | 48.90M |
| Myomo Inc | 16.52M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.39M |
| Shareholders Equity (Quarterly) | 0.4745M |